Login / Signup

Male hypogonadism: 14-year prospective outcome in 550 men with type 2 diabetes.

Nagaraj S MalipatilGhasem YadegarfarMark LuntBrian KeevilKirk SiddalsMark LivingstonSiriol RobertsPrakash NarayananMartin RutterJ Martin GibsonRachelle DonnGeoff HackettT Hugh JonesAdrian H Heald
Published in: Endocrinology, diabetes & metabolism (2019)
Low testosterone and dihydrotestosterone levels are associated with higher all-cause mortality in T2DM men. Hypogonadal men with T2DM should be considered as very high risk for cardiovascular events/death.
Keyphrases
  • cardiovascular events
  • replacement therapy
  • middle aged
  • coronary artery disease
  • cardiovascular disease
  • metabolic syndrome
  • glycemic control